Synchronous low grade endometrioid endometrial and ovarian cancer: Focus on therapeutic de-escalation proposed by the latest 2020 ESMO/ESTRO/ESP guidelines.
J Gynecol Obstet Hum Reprod
; 51(7): 102413, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35644443
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Endometrial Neoplasms
/
Carcinoma, Endometrioid
Type of study:
Guideline
Limits:
Female
/
Humans
Language:
En
Journal:
J Gynecol Obstet Hum Reprod
Year:
2022
Document type:
Article
Affiliation country:
France